kabutan

Shionogi & Co.,Ltd.(4507) Summary

4507
TSE Prime
Shionogi & Co.,Ltd.
3,180.0
JPY
+105.0
(+3.41%)
Apr 28, 3:30 pm JST
19.97
USD
Apr 28, 2:30 am EDT
Result
PTS
outside of trading hours
3,174
Apr 28, 10:33 pm JST
Summary Chart Historical News Financial Result
PER
14.3
PBR
1.79
Yield
2.23%
Margin Trading Ratio
14.47
Stock Price
Apr 28, 2026
Opening Apr 28, 9:00 am
3,145.0 JPY 19.73 USD
Previous Close Apr 27
3,075.0 JPY 19.29 USD
High Apr 28, 3:30 pm
3,180.0 JPY 19.97 USD
Low Apr 28, 9:00 am
3,070.0 JPY 19.26 USD
Volume
3,540,100
Trading Value
0.01T JPY 0.07B USD
VWAP
3160.1 JPY 19.85 USD
Minimum Trading Value
318,000 JPY 1,997 USD
Market Cap
2.83T JPY 0.02T USD
Number of Trades
4,673
Liquidity & Number of Trades
As of Apr 28, 2026
Liquidity
High
1-Year Average
4,462
1-Year High May 13, 2025
11,359
Margin Trading
Date Short Interest Long Margin Positions Ratio
Apr 24, 2026 100,400 481,100 4.79
Apr 17, 2026 109,100 443,200 4.06
Apr 10, 2026 158,100 346,200 2.19
Apr 3, 2026 165,200 286,000 1.73
Mar 27, 2026 353,200 401,800 1.14
Company Profile
Shionogi & Co., Ltd. has seen significant growth in its anti-HIV drugs. The company has strengths in hyperlipidemia medications, pain management, and the infection field. It is also accelerating its expansion into overseas markets.
Sector
Pharmaceuticals
Shionogi & Co., Ltd. engages in the research and development, procurement, manufacturing, and sales of prescription pharmaceuticals, with a particular strength in the field of infectious diseases. The company has numerous subsidiaries and affiliated companies both domestically and internationally, enabling a global business operation. Key subsidiaries include Shionogi Pharma, which handles manufacturing and contract manufacturing; Shionogi Healthcare, which develops OTC pharmaceutical business; and Shionogi TechnoAdvance Research, which provides research support for drug discovery. Overseas, Shionogi has established bases primarily in the United States, as well as in Europe and Asia, to promote local research and development and sales activities. In China, in particular, the company operates through multiple subsidiaries, demonstrating its active pursuit of expansion into foreign markets.